Skip to content
  • Home
  • About Us
  • Industry Services
    • Cosmetics & Consumer Products
    • Pharmaceuticals
    • Biocides
    • Chemicals
    • Medical Devices
    • Food & Beverages
    • Next Generation Tobacco Products (NGTP) & E-Cigarettes
  • Contact us
  • Privacy Policy

  • Home
  • About Us
  • Industry Services
    • Cosmetics & Consumer Products
    • Pharmaceuticals
    • Biocides
    • Chemicals
    • Medical Devices
    • Food & Beverages
    • Next Generation Tobacco Products (NGTP) & E-Cigarettes
  • Contact us
  • Privacy Policy

Author: sagarvati

Therapeutic Goods Administration, Australia published an updated version of Appendix 1 – Established acceptable intake for nitrosamines in medicines

 36 nitrosamines AI limits added/revised. https://www.tga.gov.au/how-we-regulate/monitoring-safety-and-shortages/industry-information-about-specific-safety-alerts-recalls-and-shortages/nitrosamine-impurities-medicines/appendix-1-established-acceptable-intake-nitrosamines-medicines

by sagarvati August 7, 2024

Scientific Advice open for comments on HC Yellow No. 16 (Colipa No. B123) – Submission II (deadline: 27 September 2024)

In the light of the data provided, SCCS considers that the use of HC Yellow No. 16 (B123) as an ingredient at 1% in oxidative

by sagarvati August 7, 2024

SCCS – Scientific Opinion open for comments on Biphenyl-2-ol and Sodium 2-biphenylolate used in cosmetic products (deadline: 27 September 2024)

In light of the data provided, the SCCS considers o-Phenylphenol and Sodium o-Phenylphenate safe when used individually as preservative up to a maximum concentration of

by sagarvati August 7, 2024
Copyright 2024. All rights reserved. Owned by Sagarvati Scientific & Regulatory Consulting LLP